NCT06299579View on ClinicalTrials.gov

GD-11 for Injection in the Treatment of Acute Ischemic Stroke

PHASE3RecruitingINTERVENTIONAL
Enrollment

980

Participants

Timeline

Start Date

February 29, 2024

Primary Completion Date

February 22, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Ischemic Stroke
Interventions
DRUG

GD-11 for injection test group

The first dose of GD-11 was administered as soon as possible after randomization and then every 12±1 hour. A total of 20 doses were required.

DRUG

Placebo control group

The first dose of placebo was administered as soon as possible after randomization and then every 12±1 hour. A total of 20 doses were required.

Trial Locations (2)

100000

NOT_YET_RECRUITING

Beijing Tiantan Hospital Capital Medical University Beijing, Beijing

041099

RECRUITING

Linfen Central Hospital, Shangxi

All Listed Sponsors
collaborator

Jiangsu Wangao Pharmaceutical Co. ltd

UNKNOWN

lead

Beijing Tiantan Hospital

OTHER